NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Neonc Technologies Holdings, Inc.
NASDAQ:NTHIHealthcare · Biotechnology
+4.49%$3.26
AH$3.12-4.29%vs close
Mkt Cap$93.91M
Float13.35M
O/S28.81M
Vol
$ Vol
RVOL
Inst Own11.0%
SI6.6%
Earnings
Dilution
Financials Summary
Revenue$40K
Net Income-$62.15M
Total Assets$2.82M
Free Cash Flow-$20.86M
Debt & Equity
Total Debt$6.31M
Total Equity-$17.51M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in NTHI's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.82M
Liabilities$20.33M
Accounts Receivable$0
Accounts Payable$7.11M
Inventory$0
PP&E (Net)$361K
Goodwill$0
Intangible Assets$500K
Income Statement
| Period | FY 2025 |
|---|---|
| Currency | USD |
| Period Ending | 2025-12-31 |
| Revenue | $40K |
| YoY Growth | - |
| Cost of Revenue | $0 |
| Gross Profit | $40K |
| Gross Margin | 100.0% |
| Research and Development | $3.64M |
| Selling, General, and Administrative | $42.85M |
| Other | $11.72M |
| Total Operating Expenses | $58.21M |
| Operating Income (EBIT) | -$58.17M |
| Operating Margin | -145459.4% |
| Interest Expense | $2.5M |
| Interest Income | $328K |
| Other Income (Expense) | -$3.98M |
| Income Before Tax (EBT) | -$62.15M |
| Income Tax Expense | $0 |
| Net Income | -$62.15M |
| Net Income Margin | -155404.4% |
| Supplementary Data | |
| EPS | -3.23 |
| Diluted EPS | -3.23 |
| Weighted Average OS | 19.21M |
| EBITDA | -$59.61M |
| EBITDA Margin | -149050.2% |
Balance Sheet
| Period | FY 2025 |
|---|---|
| Currency | USD |
| Period Ending | 2025-12-31 |
| Assets | |
| Current Assets | |
| Cash and Cash Equivalents | $59K |
| Short-Term Investments | $0 |
| Cash and Short-Term Investments | $59K |
| Accounts Receivable | $0 |
| Inventory | $0 |
| Other Current Assets | $747K |
| Total Current Assets | $1.39M |
| Long-Term Assets | |
| Property, Plant & Equipment Net | $361K |
| Goodwill | $0 |
| Intangible Assets | $500K |
| Long-Term Investments | $0 |
| Deferred Tax Assets | $0 |
| Other Long-Term Assets | $574K |
| Total Long-Term Assets | $1.43M |
| Other Assets | $0 |
| Total Assets | $2.82M |
| Liabilities | |
| Current Liabilities | |
| Accounts Payable | $7.11M |
| Short-Term Debt | $5.95M |
| Current Income Tax Payable | $0 |
| Current Unearned Revenue | $0 |
| Other Current Liabilities | $255K |
| Total Current Liabilities | $20.04M |
| Long-Term Liabilities | |
| Long-Term Debt | $0 |
| Long-Term Unearned Revenue | $0 |
| Long-Term Deferred Tax Liabilities | $0 |
| Other Long-Term Liabilities | $0 |
| Total Long-Term Liabilities | $291K |
| Other Liabilities | $0 |
| Total Liabilities | $20.33M |
| Stockholders' Equity | |
| Preferred Stock | $0 |
| Common Stock | $2K |
| Retained Earnings | -$112.75M |
| Comprehensive Income & Other | $0 |
| Other Stockholders' Equity | $95.24M |
| Total Equity | -$17.51M |
| Minority Interest | $0 |
| Total Liabilities and Equity | $2.82M |
| Supplementary Data | |
| Total Debt | $6.31M |
| Net Debt | $6.26M |
Cash Flow Statement
| Period | FY 2025 |
|---|---|
| Currency | USD |
| Period Ending | 2025-12-31 |
| Operating Activities | |
| Net Income | -$62.15M |
| Depreciation & Amortization | $36K |
| Deferred Income Tax | $0 |
| Stock-Based Compensation | $35.56M |
| Changes in Working Capital: | |
| Accounts Receivable | $0 |
| Inventory | $0 |
| Accounts Payable | $1.12M |
| Other Working Capital | $1.02M |
| Total Working Capital Change | $2.14M |
| Other Non-Cash Items | $4.05M |
| Net Cash from Operating | -$20.36M |
| Investing Activities | |
| Capital Expenditures | -$500K |
| Acquisitions | $0 |
| Purchases of Investments | $0 |
| Sales of Investments | $0 |
| Other Investing Activities | $0 |
| Net Cash from Investing | -$500K |
| Financing Activities | |
| Debt Repaid | -$4M |
| Common Stock Issuance | $17.16M |
| Common Stock Repurchases | $0 |
| Dividends Paid | $0 |
| Other Financing Activities | $0 |
| Net Cash from Financing | $20.86M |
| Forex Effect | $0 |
| Net Change in Cash | -$6K |
| Supplementary Data | |
| Operating Cash Flow | -$20.36M |
| Capital Expenditure | -$500K |
| Free Cash Flow | -$20.86M |
| Cash at Beginning | $65K |
| Cash at End | $59K |